Glycovaxyn AG

📍 Switzerland👥 3 employees💰 Last funded May 2005
Hospitals and Health Care🌐 glycovaxyn.com
Website LinkedIn
GlycoVaxyn is a private Swiss biotechnology company developing a broad portfolio of novel bioconjugate vaccines to prevent and treat common, severe bacterial infections using its proprietary glycoprotein technology.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Glycovaxyn AG?
Glycovaxyn AG has 1 investors on record on gritt.io.
When did Glycovaxyn AG last raise funding?
The most recent investment in Glycovaxyn AG recorded on gritt.io was in May 2005.
What industry is Glycovaxyn AG in?
Glycovaxyn AG operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is Glycovaxyn AG based?
Glycovaxyn AG is headquartered in Switzerland.